LA County Harbor-UCLA Medical Center
Welcome,         Profile    Billing    Logout  
 0 Trials 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ward, Katherine
NCT05143177: A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease with Mild to Moderate Aortic Stenosis (EVOID-AS)

Active, not recruiting
2/3
867
Canada, US
Evogliptin, DA-1229, Placebo
REDNVIA Co., Ltd.
Calcific Aortic Valve Disease
05/26
12/26
NCT05669365: The Care Ecosystem Consortium Effectiveness Study

Active, not recruiting
N/A
2550
US
Care Ecosystem
University of California, San Francisco, Ochsner Health System, Providence Health & Services, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, HealthPartners Institute, University of Colorado, Denver, National Institute on Aging (NIA)
Dementia, Dementia, Vascular, Dementia With Lewy Bodies, Dementia Alzheimers, Frontotemporal Dementia
12/25
12/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ward, Katherine
NCT05143177: A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease with Mild to Moderate Aortic Stenosis (EVOID-AS)

Active, not recruiting
2/3
867
Canada, US
Evogliptin, DA-1229, Placebo
REDNVIA Co., Ltd.
Calcific Aortic Valve Disease
05/26
12/26
NCT05669365: The Care Ecosystem Consortium Effectiveness Study

Active, not recruiting
N/A
2550
US
Care Ecosystem
University of California, San Francisco, Ochsner Health System, Providence Health & Services, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, HealthPartners Institute, University of Colorado, Denver, National Institute on Aging (NIA)
Dementia, Dementia, Vascular, Dementia With Lewy Bodies, Dementia Alzheimers, Frontotemporal Dementia
12/25
12/25

Download Options